4.6 Article

Loss of statin treatment years during pregnancy and breastfeeding periods in women with familial hypercholesterolemia

期刊

ATHEROSCLEROSIS
卷 335, 期 -, 页码 8-15

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2021.09.003

关键词

Familial hypercholesterolemia; Pregnancy; Statin; Breastfeeding; Women's health

资金

  1. University of Oslo, Oslo
  2. Norwegian National Advisory Unit on FH, Oslo University Hospital, Oslo, Norway
  3. Throne-Holst Foundation for Nutrition Research, Oslo, Norway

向作者/读者索取更多资源

This study aimed to determine the duration of off-statin periods in women with familial hypercholesterolemia during pregnancy and breastfeeding. The results showed that Norwegian women breastfed more and longer compared to Dutch women, with the majority of women expressing the need for more information on pregnancy and breastfeeding related to FH.
Background and aims: Women with heterozygous familial hypercholesterolemia (FH) are recommended to initiate statin treatment at the same age as men (from 8 to 10 years of age). However, statins are contraindicated when pregnancy is planned, during pregnancy and breastfeeding. The aim of the study was to determine the duration of pregnancy-related off-statin periods and breastfeeding in FH women. Methods: A cross-sectional study using an anonymous online self-administered questionnaire was conducted. Women with FH were recruited through Lipid Clinics in Norway and Netherlands and national FH patient organizations. Results: 102 women with FH (n = 70 Norwegian and n = 32 Dutch) were included in the analysis. Total length of pregnancy-related off-statin periods was estimated for 80 women where data were available, and was median (min-max) 2.3 (0-14.2) years. Lost statin treatment time was estimated for 67 women where data were available, and was median (min-max) 18 (0-100)% at mean (SD) age of 31 (4.3) years at last pregnancy. More women breastfed in Norway (83%) and for longer time [8.5 [1-42] months] compared to the Netherlands [63%, p = 0.03; 3.6 (0-14) months, p < 0.001]. Eighty-six percent of the women reported need for more information on pregnancy and breastfeeding in relation to FH. Conclusions: Young FH women lose years of treatment when discontinuing statins in relation to pregnancy and breastfeeding periods and should be closely followed up to minimize the duration of these off-statin periods. Whether these periods of interrupted treatment increase the cardiovascular risk in FH women needs to be further elucidated.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据